CNB Bank’s Definium Therapeutics DFTX Stock Holding History

CNB Bank’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$470	Buy	+10	New	+$247	﹤0.01%	509
2026 Q1	–	Sell	-10	Closed	-$134	–	529
2025 Q4	$134	Hold	10	–	–	﹤0.01%	503
2025 Q3	$118	Hold	10	–	–	﹤0.01%	501
2025 Q2	$65	Hold	10	–	–	﹤0.01%	499
2025 Q1	$59	Hold	10	–	–	﹤0.01%	488
2024 Q4	$70	Hold	10	–	–	﹤0.01%	495
2024 Q3	$57	Hold	10	–	–	﹤0.01%	522
2024 Q2	$72	Hold	10	–	–	﹤0.01%	506
2024 Q1	$94	Hold	10	–	–	﹤0.01%	492
2023 Q4	$37	Hold	10	–	–	﹤0.01%	481
2023 Q3	$31	Hold	10	–	–	﹤0.01%	492
2023 Q2	$36	Hold	10	–	–	﹤0.01%	441
2023 Q1	$32	Hold	10	–	–	﹤0.01%	480
2022 Q4	$22	Buy	+10	New	+$28	﹤0.01%	457
2022 Q3	–	Sell	-10	Closed	–	–	478
2022 Q2	$0	Buy	+10	New	+$127	﹤0.01%	498
2022 Q1	–	Sell	-10	Closed	–	–	516
2021 Q4	$0	Hold	10	–	–	﹤0.01%	479
2021 Q3	$1K	Buy	+10	New	+$432	﹤0.01%	402

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

CNB Bank's DFTX Position: Q2 2026 in Review

CNB Bank opened a new position in Definium Therapeutics (DFTX) in Q2 2026: 10 shares worth $470. The stake represents ﹤0.01% of the portfolio and ranks #509 among its holdings. This is a return to the name: CNB Bank previously reported a position in DFTX as recently as Q4 2025.

CNB Bank first reported a position in DFTX in Q3 2021 and has held it in 17 quarters since. The position peaked at $1K in Q3 2021. 362 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

CNB Bank held 10 shares of Definium Therapeutics worth $470 as of Q2 2026.
Definium Therapeutics was a new CNB Bank position in Q2 2026.
Definium Therapeutics made up ﹤0.01% of CNB Bank's portfolio in Q2 2026, its #509 holding.
CNB Bank first reported a position in Definium Therapeutics in Q3 2021 and has held it in 17 quarters since.
CNB Bank's Definium Therapeutics position peaked at $1K in Q3 2021.
362 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on CNB Bank's 13F filing for Q2 2026, filed 6 Aug 2026.